Aquestive Therapeutics appoints Rich Daly to board of directors
AQST•Aquestive Therapeutics appointed Rich Daly to its board, effective Oct. 14, 2026. The board will have eight directors following the appointment.
1. Board appointment
Daly brings more than 30 years of biopharma leadership, including commercial and operating roles at AstraZeneca, Takeda and Catalyst.
